Professional Summary
Professional Overview
Tim Kelly is the Chief Executive Officer of RoosterBio Inc., a leading provider of innovative, scalable, and cost-effective stem cell technologies. With over 20 years of experience in the biopharmaceutical industry, Tim brings a wealth of expertise in biopharmaceutical development, operations, and manufacturing.
Experience Summary
Current Role
As the CEO of RoosterBio Inc., Tim is responsible for driving the company's strategic vision and overseeing all aspects of its operations. He is focused on expanding the company's capabilities, fostering innovation, and delivering cutting-edge stem cell solutions to its global client base.
Career Progression
Prior to joining RoosterBio, Tim served as the President, Manufacturing at Asklepios BioPharmaceutical, Inc. (AskBio), where he led the company's manufacturing operations and helped drive its growth. Before that, he held various leadership roles at KBI Biopharma, including President and CEO, Executive Vice President of Operations, and Vice President of Biopharmaceutical Development. Earlier in his career, Tim served as the Director of Quality Control at Diosynth Biotechnology.
Academic Background
Tim holds a Bachelor of Science degree in Chemistry from the University of North Carolina at Chapel Hill.
Areas of Expertise
- Biopharmaceutical development and manufacturing
- Stem cell technology and innovation
- Operational excellence and process optimization
- Strategic leadership and business development
- Quality assurance and regulatory compliance
Professional Impact
Throughout his career, Tim has been instrumental in driving the success of the companies he has been associated with. He has led the development and implementation of innovative biopharmaceutical solutions, streamlined manufacturing processes, and fostered collaborative partnerships that have had a significant impact on the industry.
Conclusion
With his deep industry expertise, proven leadership, and unwavering commitment to innovation, Tim Kelly is well-positioned to guide RoosterBio Inc. to new heights as it continues to pioneer advancements in the stem cell technology field.
